🔗 Share this article

Acclaimed R&B singer D’Angelo died on October 14 at 51 years old after a personal fight with pancreatic cancer.

“The shining star of our household has dimmed his light for us in the present world,” his family stated. “After a lengthy and courageous battle with cancer, we are heartbroken to announce that D’Angelo, recognized by his fans around the globe as D’Angelo, has been called home.”

D’Angelo left an indelible mark on music with his innovative modern soul style and partnerships with renowned musicians.

He released his debut album, “Brown Sugar,” in 1995 to immediate acclaim. The record achieved the fourth spot on Billboard’s Top R&B Albums chart, earned platinum status soon after, and earned multiple Grammy nominations.

However, it was his sophomore release, “Voodoo,” in 2000 that boosted his artistic journey into the stratosphere. The record premiered at No. 1 on each of the R&B charts and the Billboard 200. He won two Grammy Awards: Best R&B Album and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” cemented D’Angelo’s reputation as a sex symbol, albeit a reluctant one, in the public consciousness. The personal depiction featured the artist, notably stripped down to his waist, performing directly into the camera.

D’Angelo stepped back from the spotlight after releasing Voodoo and openly battled with substance abuse. In 2005, he was involved in a serious car crash that left him in critical condition.

More than a decade later, his third and final album, “Black Messiah” (2014), reaffirmed his enduring appeal with a further top chart entry on the R&B chart and a award for Top R&B Record.

Again, in his own enigmatic fashion, D’Angelo made only a few public outings in the subsequent period.

The musician was announced as a top act for the 2025 music event, but his appearance was canceled, citing an “unexpected health issue.”

Even though information is limited about D’Angelo’s health in the months leading up to his death, he had apparently been hospitalized for an extended period and in palliative care for a fortnight.

D’Angelo’s demise is a stark reminder of the harmful impact of pancreatic malignancy, one of the deadliest and hardest to prevent forms of the disease, on a brilliant talent whose existence was cut short.

“We are saddened that he can only provide dear memories with his family, but we are eternally grateful for the legacy of extraordinarily moving songs he has left us,” his kin said.

Pancreatic Cancer: Lethal and Difficult to Avoid

Pancreatic malignancy impacts the digestive organ, a small organ that generates the hormone insulin and plays an essential role in digestion, among additional roles. The size and location of the organ in the human system make it more difficult to identify cancer.

Even though pancreatic cancer accounts for only about 3% of cancer diagnoses annually in the U.S., it is responsible for 7% of malignancy fatalities.

Almost seventy thousand individuals will be diagnosed with pancreatic cancer and roughly fifty-two thousand will die of the illness in 2025.

“This malignancy is one of the most lethal diseases, with an fast-growing mass and poor prognosis. We have few and poor treatment options, and a smaller window to make a meaningful impact on the well-being of people,” said a cancer specialist.

Since this disease seldom produces early symptoms, it’s frequently identified only once the disease is advanced. Even when a patient has symptoms they are often vague and may be mistaken for a several everyday ailments.

“Currently, there is no good way to identify pancreatic cancer in the early stages, except for listening to your body and consulting your physician if there are new or unusual symptoms,” said a medical director.

Common symptoms of pancreatic cancer include:

• abdominal or lower back pain
• weight loss
• jaundice
• loss of appetite
• dark urine
• pale or fatty bowel movements
• loose stools
• increased appetite or thirst
• feeling sick

At 51 years old, D’Angelo’s death is an outlier, as this malignancy is most common in individuals in the sixty-five to seventy-five range. However, many cancers, such as this type, have become increasingly prevalent in younger people.

“Pancreatic cancer identified before the age of 50 is considered rare, yet alarmingly, clinicians are noticing a growing number of younger individuals suffering from this disease,” commented a expert.

Family History Impacts Disease Probability

In the absence of reliable screening tools for this malignancy, professionals emphasized the importance of knowing your relatives’ health background. Certain risk factors, such as smoking and obesity also have an influence in the development of this disease.

African Americans have the highest incidence of this malignancy in the U.S. and are most likely to be diagnosed with untreatable disease.

“The first step toward reducing one’s chance of pancreatic cancer is understanding personal risk factors. People should examine their genetic background, hereditary factors, and health issues, such as blood sugar disease, chronic pancreatitis, or obesity that may increase their susceptibility,” said a specialist.

Hereditary risk factors are linked to as much as ten percent of all this malignancy instances. If someone in your household has had pancreatic cancer, you may want to consider genetic testing.

“For people with a family history of pancreatic cancer or those having high risk DNA changes, screening may involve advanced imaging such as magnetic resonance imaging (MRI) or endoscopic ultrasound (EUS) to find early changes in the organ,” he explained.

For those wishing to lower their chance, habit adjustments may have an effect. The most effective action you can take to lower your risk of pancreatic cancer is to stop tobacco use, and if you don’t smoke, avoid exposure altogether.

Heavy drinking is linked to pancreatitis, a contributing element for pancreatic cancer, so reducing or abstaining from alcohol may assist reduce your risk.

Controlling your weight or shedding pounds may also help decrease your susceptibility. People with obesity are twenty percent more prone to get this disease. This malignancy also occurs more often in people with diabetes, and weight loss can also reduce the risk of type 2 diabetes.

Despite this disease’s poor prognosis, there is still hope.

“We are doing better with treatments and more recent combination chemotherapy. There are emerging targeted therapies that are already making an impact,” remarked a expert.

For numerous people, however, education about this rare but {dev